Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Camille L. Gérard
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Clinical Validation of a Prognostic 11-Gene Expression Profiling Score in Prospectively Collected FFPE Tissue of Patients With AJCC V8 Stage II Cutaneous Melanoma
European Journal of Cancer
Cancer Research
Oncology
Considering Adjuvant Therapy for Stage II Melanoma
Cancer
Cancer Research
Oncology
784 a New Immune Evasion Mechanism in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Progress in Understanding Complexity and Determinants of Immune-Related Prognostic Subsets in Primary Melanoma
Cancer Research
Cancer Research
Oncology
Cell Kinetics: An Independent Prognostic Variable in Stage II Melanoma of the Skin
British Journal of Cancer
Cancer Research
Oncology
H3K27me3 and EZH2 Expression in Melanoma: Relevance for Melanoma Progression and Response to Immune Checkpoint Blockade
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
Immune Checkpoint Inhibitors in Melanoma: Review and Update
Journal of the Portuguese Society of Dermatology and Venereology
Is There a Role for Immune Checkpoint Blockade in Metastatic Uveal Melanoma?
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?
Journal of the American Academy of Dermatology
Dermatology